Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
about
Novel perspectives on mucormycosis: pathophysiology, presentation, and management.Mucormycosis, pseudallescheriasis, and other uncommon mold infectionsRecent advances in the management of mucormycosis: from bench to bedsideActive and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infectionBiology, systematics, and clinical manifestations of Zygomycota infectionsCombination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.Recent advances in the treatment of mucormycosis.Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosisHow should we manage a patient with invasive mucoromycosis who develops life-threatening reaction to amphotericin B? Report of two cases and literature review.Human Fungal Pathogens of Mucorales and Entomophthorales.Antifungal pharmacokinetics and pharmacodynamicsCombination therapy for mucormycosis: why, what, and how?Echinocandin antifungals: review and update.The pharmacology and clinical use of caspofungin.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).Combination antifungal therapy: the new frontier.Drug combinations against Mucor irregularis in vitro.Immunocompromised hosts: immunopharmacology of modern antifungals.In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.Invasive mold infections: recent advances in management approaches.Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosisThe role of fungi in diseases of the nose and sinusesPharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.Managing fungal and viral infections in pediatric leukemia.Rhino-orbital-cerebral mucormycosis.Our 2014 approach to mucormycosis.Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature.Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.Combination therapy for the treatment of pulmonary mold infections.Invasive mold infections: virulence and pathogenesis of mucorales.Invasive mould infections in the ICU setting: complexities and solutions.Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.Combination echinocandin-polyene treatment of murine mucormycosis.In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agentsPosaconazole mono- or combination therapy for treatment of murine zygomycosis.Emerging fungal infections in solid organ transplantation.Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
P2860
Q24530554-1408877B-8D10-4D66-9916-78E560573897Q24603297-1BC7C465-0266-4F10-8C4C-66AE39B56274Q24642450-12B7E337-8C87-450E-8B48-69697B054928Q28478751-C6BFA1D2-E6A2-4564-A493-E54C17844B67Q28656453-E7AFD537-F385-483B-9B07-2F3C765F49BAQ30873926-FD25E244-0D2A-46EB-A7C6-DD0AD4AEC271Q34161213-4CB39DE6-3414-419E-8BD0-71D29193A914Q35065748-16E1C073-5F84-4C21-A841-F377AD1D9793Q35196776-2EEA91EA-A7FF-40F8-8946-E05B367ED1A9Q35245238-89B7F9B2-BDA5-4678-81F1-8D5C492D69BBQ35663841-998AD15F-E73A-4321-928F-272CC512F300Q35974333-8968F450-EE2C-4F65-9A5B-B9426A1DFF3EQ36441524-9839D6E6-CD08-43F2-9A94-BC8D75A71F3BQ36788428-B191E35E-8EF1-4AC0-9EF1-7D5DEA67E1E3Q36825717-FC3422EE-93EE-4FCA-8E73-F0FAD5827A8CQ36862446-AABB0B62-E77E-43DD-8C8C-BB9F7A42EF63Q36895652-34D69C60-3B01-4497-9BB9-ECC55DB9C35DQ36969929-6DF32EAF-040A-4884-92BC-F00850DE3005Q37186705-E19CE232-178B-4177-8506-A4E8B5AC4BA6Q37274705-20DBBAE3-1E09-4AB2-9E17-A6A44A7492D3Q37428946-E6FF6E8E-0598-430F-841E-21873430872AQ37475959-153B3D45-3FCF-40B6-B2A3-EC4821B1908FQ37522264-76D37FB2-8CBF-4C97-8E03-40D60090347BQ37785979-304FB778-5543-4D36-9E87-16A113112D38Q37810281-FA280D41-D595-4075-AC42-691B1D970E4BQ38017577-C4C934C3-FAEE-456E-96BB-E60384693D39Q38211830-7A1BC5DE-307B-47C8-89DC-9FDC09EBF6C2Q38215757-DE481009-78C4-4BC1-A8B4-EF2D75513C37Q38245046-89B2937B-01B4-4B67-8DF1-143846221537Q38633105-885D4CF5-BEBB-460B-842A-5DA8AF572AE9Q38806932-53926B05-C8DD-4871-87D4-44F7D1F22551Q38909410-0548D54A-54E0-4B69-91A3-A9AF7EDD90D4Q39206915-5AA8C180-3317-49DD-90F3-58304900CA1CQ40116878-156652DE-8686-40D7-9D98-C3C2DFF26193Q40474311-A1FE4ECE-F2E2-4875-9E86-984A4B245415Q41904884-A3516AF9-2A6D-4062-B5CC-D09BA311E106Q42139858-6E313A08-A2AC-4C72-A0AA-70718B13152BQ42183489-EA5D949A-8A0D-4388-99C9-931D08DCF73CQ42272283-CA50BACD-B371-4E2A-8AFC-45D4081E792FQ42627361-DB10FF7B-81A8-4D54-B587-10BCE3FDF6A5
P2860
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Combination therapy with ampho ...... in diabetic ketoacidotic mice.
@ast
Combination therapy with ampho ...... in diabetic ketoacidotic mice.
@en
type
label
Combination therapy with ampho ...... in diabetic ketoacidotic mice.
@ast
Combination therapy with ampho ...... in diabetic ketoacidotic mice.
@en
prefLabel
Combination therapy with ampho ...... in diabetic ketoacidotic mice.
@ast
Combination therapy with ampho ...... in diabetic ketoacidotic mice.
@en
P2093
P2860
P1476
Combination therapy with ampho ...... in diabetic ketoacidotic mice.
@en
P2093
Ashraf S Ibrahim
Brad Spellberg
John E Edwards
P2860
P304
P356
10.1128/AAC.49.2.830-832.2005
P407
P577
2005-02-01T00:00:00Z